Algatech Opens New US Subsidiary

5760b5a2-7a62-4840-89fd-f0780c78c6adarticleimage.jpg

15 Jun 2017 --- Algatech has opened Algatech Inc., a New York City-based subsidiary created to serve its customers in the North American market. The company is appointing Ken Seguine to lead the new operation. Algatech’s expansion into the US will accelerate development of the growing market in North America for its leading microalgae ingredient brand, AstaPure, as well as new microalgae sources in the pipeline. 

Algatech Inc.’s responsibilities will include the US, Canada and Mexico. Gary Brenner, who was responsible for Algatech’s business development in the NAFTA markets since 2010, will lead the algal protein development project as part of the European Institute of Innovation and Technology consortium (EIT Food).

Click to EnlargeSpeaking about the company’s growth, Efrat Kat, ‎VP Marketing & Sales at Algatechnologies, tells NutritionInsight that “in the last six months or so we recruited an entire team of R&D people, including a head of business development who will focus on new product development. We are expanding our team, but also our presence in the market. We are looking to recruit more people for our team, and we are also conducting more clinical studies for our astaxanthin and other products.”

“[Algatech] has the know-how, the experience and the right infrastructure and locations, there is still a lot of potential untapped in the microalgae industry and we are fascinated about further developing this industry,” Kat says.

Ken Seguine served as VP Sales and Marketing of UAS Laboratories 2013-2017 and was Executive VP consumer products at Savesta Life Sciences Inc. He brings more than 25 years of experience in the natural products industry with companies in both dietary supplements and personal care.

“We are committed to expanding our global marketing network and strengthening our presence in the NAFTA markets,” says Algatech CEO Hagai Stadler. “This includes highly qualified personnel recruitment, new product developments, and growing Algatech’s operation facilities in the Arava desert, Israel.”

“I’m excited to join the team at Algatech and help them better serve the North American market with our new organic and non-GMO ingredients,” says Seguine. “Algatech specializes in the development and production of ingredients derived from algae. I am looking forward to contributing my background in organic agriculture, cosmetics and dietary supplements to the company’s activities.”

Click to EnlargeAlgatech was chosen by the EIT’s Knowledge and Innovation Communities (KIC) leaders to be the sole algae producer, especially to develop new food sources from microalgae via its advanced technologies and capabilities. Algatech intends to invest heavily in developing plant-based protein from microalgae in cooperation with global ingredient companies.

“Algatech is focused on natural microalgae solutions,” says Stadler. “It cultivates microalgae in a patented, eco-friendly, closed system that allows the production of safe, pure ingredients and minimize its environmental footprint. The company works relentlessly to unlock the potential of microalgae, discovering and industrializing new strains of microalgae, and producing it in large scale through methods completely beneficial to both consumers and the planet.”

Related Articles

Nutrition & Health News

The US Council for Responsible Nutrition welcomes eight new companies as members

30 Jan 2018 --- The Council for Responsible Nutrition (CRN), a US trade association for the dietary supplement and functional food industry, has welcomed eight new companies to its membership ranks.

Nutrition & Health News

Non-GMO astaxanthin: Algalif achieves verification

24 Jan 2018 --- Algalif, an Icelandic producer of pure, high-grade, natural astaxanthin from microalgae, has achieved Non-GMO Project verification for its Astalíf 5% and 10% oleoresin ingredients.

Nutrition & Health News

Valensa International obtains two US patents for joint health formulations

04 Oct 2017 --- The US Patent and Trademark Office has awarded Florida-based Valensa International two new patents, locking down patent protection for the core ingredients related to the company’s FlexPro MD and FlexPro ES. In clinical trials, these dietary formulations for joint health were shown to be three to five times more effective in relieving joint discomfort than a standard commercial formulation of glucosamine and chondroitin. 

Nutrition & Health News

Beauty from within presents attractive options despite regional challenges

29 Sep 2017 --- The beauty-from-within space has been gaining traction over recent years, with a number of key ingredients piquing the interest of consumers and suppliers alike. Today, NutritionInsight looks at some of the regional differences, challenges and opportunities this space offers.

Business News

Kemin and Valensa partner on algae-sourced beta-glucans for immunity

29 Sep 2017 --- Kemin Industries and Valensa International have partnered up to jointly supply and market BetaVia ingredients, immune-supporting beta-glucans sourced from a proprietary strain of algae (Euglena gracilis), in the US dietary supplement and functional food and beverage markets. 

More Articles
URL : http://www.nutritioninsight.com:80/news/algatech-opens-new-us-subsidiary.html